| 17.04.2024 08:00:43 | |
|---|---|
| Cena | |
| 117,80 EUR | |
| Změna | -0,67% (-0,80) |
Základní údaje
| ISIN | US58933Y1055 |
| Symbol | MRK |
| Burza | Hamburg |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 297.627 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | - |
| Prodej (částka) | - |
| Otevírací cena | 117,80 EUR |
| Max | 117,80 EUR |
| Min | 117,80 EUR |
| Závěrečná cena (předchozí den) | 118,60 EUR |
| Cena vážená obchodovaným objemem | - |
| Objem (kusy) | 0 |
| Obchodovaný objem | 0,00 |
| Počet obchodů | 3 |
| Poslední zobchodovaný počet | 0 |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: MERCK & CO. INC. |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 03.04.2024 |
|
Global Equity Ratings |
|
| 13.03.2024 |
|
Global Equity Ratings |
|
| 22.02.2024 |
|
Global Equity Ratings |
|
| 14.02.2024 |
|
Global Equity Ratings |
|
| 23.01.2024 |
|
Global Equity Ratings |
|
Všechny burzy pro MERCK & CO. INC.
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 17.04.2024 | 17:35 | 117,60 EUR | 0,06 | 26 |
| Vienna Stock Exchange | 17.04.2024 | 17:32 | 117,80 EUR | 0,00 | 2 |
| Tradegate | 17.04.2024 | 22:26 | 117,60 EUR | 0,31 | 63 |
| Stuttgart | 17.04.2024 | 19:16 | 117,20 EUR | 0,00 | 8 |
| SIX Swiss Exchange | 05.12.2022 | 17:36 | 400,00 CHF | 0,00 | 1 |
| SIX Swiss Exchange | 03.02.2020 | 17:36 | 75,00 USD | 0,00 | 1 |
| NYSE | 17.04.2024 | 22:00 | 125,37 USD | 767,46 | 86.211 |
| Munich | 17.04.2024 | 14:53 | 117,80 EUR | 0,02 | 2 |
| London Stock Exchange | 17.04.2024 | 17:35 | 125,60 USD | 0,00 | 5 |
| Hanover | 17.04.2024 | 08:00 | 117,80 EUR | 0,00 | 3 |
| Hamburg | 17.04.2024 | 08:00 | 117,80 EUR | 0,00 | 3 |
| Frankfurt | 17.04.2024 | 16:46 | 118,20 EUR | 0,00 | 1 |
| Euronext Milan MTF Trading After Hours | 12.03.2024 | 18:49 | 112,00 EUR | 0,00 | 2 |
| Euronext Milan MTF Global Equity Market | 17.04.2024 | 17:44 | 118,20 EUR | 0,00 | 1 |
| Duesseldorf | 17.04.2024 | 19:30 | 117,00 EUR | 0,00 | 7 |
| Berlin | 17.04.2024 | 20:21 | 117,00 EUR | 0,00 | 17 |
| 17.04.2024 08:00:43 | |
|---|---|
| Cena | |
| 117,80 EUR | |
| Změna | -0,67% (-0,80) |
Základní údaje
| ISIN | US58933Y1055 |
| Symbol | MRK |
| Burza | Hamburg |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 297.627 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | - |
| Prodej (částka) | - |
| Otevírací cena | 117,80 EUR |
| Max | 117,80 EUR |
| Min | 117,80 EUR |
| Závěrečná cena (předchozí den) | 118,60 EUR |
| Cena vážená obchodovaným objemem | - |
| Objem (kusy) | 0 |
| Obchodovaný objem | 0,00 |
| Počet obchodů | 3 |
| Poslední zobchodovaný počet | 0 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | +19,59% | +12,40% | +82,66% |
| Výkonn. (abs.) | +19,30 | +13,00 | +53,31 |
| Beta | 0,30 | 0,30 | 0,27 |
| Volatilita | 20,63 | 20,20 | 23,79 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 118,04 EUR (0) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 115,63 EUR (5) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 109,39 EUR (16) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 103,82 EUR (26) |
| YTD Max| datum | 122,40 EUR (02.04.2024) |
| YTD Min | datum | 98,40 EUR (02.01.2024) |
| 52týdenní max. | datum | 122,40 EUR (02.04.2024) |
| 52týdenní min. | datum | 91,00 EUR (29.11.2023) |
Logo společnosti
Kontakty
| MERCK & CO. INC. |
| - - |
| 126 East Lincoln Avenue - 07065 Rahway |
| Telefon:+1-908-740-4000 |
| Fax:+ |
| E-mail:- |
PDF ke stažení
| Report společnosti: MERCK & CO. INC. | |
Profil společnosti
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. |
Členové představenstva
| Christine Seidman | Member of Board of Directors |
| Paul Rothman | Member of Board of Directors |
| Risa Lavizzo-Mourey | Member of Board of Directors |
| Stephen Mayo | Member of Board of Directors |
| Douglas Baker | Member of Board of Directors |
| Inge Thulin | Member of Board of Directors |
| Kathy Warden | Member of Board of Directors |
| Mary Coe | Member of Board of Directors |
| Pamela Craig | Member of Board of Directors |
| Patricia Russo | Member of Board of Directors |
| Peter Wendell | Member of Board of Directors |
| Thomas Glocer | Member of Board of Directors |
| Robert M. Davis | Chairman of Managing Board |
| Caroline Litchfield | Member of Executive Committee |
| Chirfi Guindo | Member of Executive Committee |
| Cristal N. Downing | Member of Executive Committee |
| Dave Williams | Member of Executive Committee |
| Dean Y. Li | Member of Executive Committee |
| Jannie Oosthuizen | Member of Executive Committee |
| Jennifer Zachary | Member of Executive Committee |
| Joseph Romanelli | Member of Executive Committee |
| Michael A. Klobuchar | Member of Executive Committee |
| Richard R. DeLuca Jr. | Member of Executive Committee |
| Sanat Chattopadhyay | Member of Executive Committee |
| Steven C. Mizell | Member of Executive Committee |